Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$342K Sell
8,161
-350
-4% -$16K ﹤0.01% 1325
2026
Q1
$362K Buy
8,511
+2,057
+32% +$101K ﹤0.01% 1172
2025
Q4
$313K Buy
6,454
+232
+4% +$11.6K ﹤0.01% 1154
2025
Q3
$328K Sell
6,222
-1,098
-15% -$59.2K ﹤0.01% 1115
2025
Q2
$351K Sell
7,320
-7,159
-49% -$299K ﹤0.01% 1079
2025
Q1
$627K Buy
14,479
+492
+4% +$24.5K 0.01% 864
2024
Q4
$720K Buy
13,987
+606
+5% +$32.5K 0.01% 838
2024
Q3
$674K Sell
13,381
-543
-4% -$25.2K 0.01% 834
2024
Q2
$532K Buy
+13,924
New +$544K 0.01% 893

Other funds holding LAZ

Xponance's LAZ Position: Q2 2026 in Review

Xponance reduced its Lazard (LAZ) stake by 4.1% in Q2 2026, selling an estimated $16K and leaving 8,161 shares worth $342K. The position accounts for ﹤0.01% of the portfolio, ranked #1325.

Xponance first reported a position in LAZ in Q2 2024 and has held it in 9 quarters since. The position peaked at $720K in Q4 2024. 345 funds tracked by Wall St. Rank hold LAZ as of Q2 2026.

  • Xponance held 8,161 shares of Lazard worth $342K as of Q2 2026.
  • Xponance sold 350 Lazard shares in Q2 2026, an estimated $16K.
  • Lazard made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1325 holding.
  • Xponance first reported a position in Lazard in Q2 2024 and has held it in 9 quarters since.
  • Xponance's Lazard position peaked at $720K in Q4 2024.
  • 345 funds tracked by Wall St. Rank held Lazard as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.